MME Anne SIMON

Rhumatologue

RPPS 10000497403

📊 Reconnaissance scientifique : 47/100📝 239 articles publiés🇫🇷 Publications académiques françaises (8)

✨ Génération du profil synthétique IA en cours…

Activité de recherche & publications

Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.

Influence scientifique

47 articles ont été cités au moins 47fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Articles de presse (10)

Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).

Anne Simon : « L’humain ne sort jamais de l’animalité » - revue-ballast.fr

📰 revue-ballast.fr · 23/10/2021

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxNU0RYeUFSZDNRaFo0Umd3QURMYmlHcWFpaTlyNEw4VTA3ajBUanR2TjdUeDJDRjJIU2NJNmQ1NEp6OWxlWjFTaDB5WTZfX2xFbnZfNFlyTVItQ1hNVXVfVm9MOWc5T2FFbkNTRDVrcGpITG4taXZZLXFvM0piS3pyMVV2bw?oc=5" target="_blank">Anne Simon : « L’humain ne sort jamais de l’anima

En Maine-et-Loire, ils construisent un habitat inclusif pour les personnes en situation de handicap - Ouest-France

📰 Ouest-France · 08/11/2023

<a href="https://news.google.com/rss/articles/CBMirwJBVV95cUxOTjM3RmFjMDdfanNRWVFVTFBQQkZOVWcwM203aWYweEFaTl95UnB2VGw4LTRKa0UxMDVhZnM4czN0aFRHdG4yQXFEdmpTd29TRTdqZG00QzN1ZzdZaENEMlhYcm1Ib25tUWNqVUwwdDB1QnJUTThJX2FJU3pTYjR4NU5Sb1VETXlZRWFQRFQyU250ckZfNEUtZFFwVzQwR1BNbzd0NTAxR2VMZ2w0WVk4QmlNa1ZfTUhxdm

S’alimenter selon sa typologie - L'Indépendant

📰 L'Indépendant · 26/11/2018

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxQc2xpQXR6MVRQZWtuUFk0MHdVbGVleC1FaGJWcDZVWWxjcFlwejY2N3ZZbXVGOWtmdXNFRGcxamlrVDczZnpZTGpXZHdCU2RXUHh0NEltMGFhOXJtVkRSeWVuN0t0ZmtXblJUTElzNUY2VHNJRk13Sy1TNVRyODNlLUVBSGxwclU?oc=5" target="_blank">S’alimenter selon sa typologie</a> <font col

Ecologie : les savons solides sont-ils bons pour la santé ? - RTBF

📰 RTBF · 07/02/2022

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOY0M1eW51Xzhka25kZncxTjdUakJya1BFSGFSRzVBWTlKUVpwMjExckRneTlvc0lOVXVnV25aRXU2TWl0ME8tclFPUXhnUDNhRllVSUVKVml5S1VDZ2g5Q1BYVl9FdXNMZjMySzVneXZibF93bWFWNUpUam9VVWw2QnVVWVpBSUltYTBTbG9XUzBjdVAySUpV?oc=5" target="_blank">Ecologie : les savons s

La grippe est de retour... et le port du masque aussi: "Ce sont des mauvais souvenirs qui reviennent" - RTL Info

📰 RTL Info · 10/01/2025

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxQZVdOZ2NlYnFWbWtqdVotWTJ5cVN1MGtXMU5DVlJIUDZIWUlnWUdIOEFnbTNlSURLUldfV3J4S0ZHWEI1eV9GVURpRXRuVDYwYnFyYWZqM1VvNmhTWHZVaU5MYUJrTC1QUDZINmJhRUdPb0poUmZlZFdaemRGdUtFR2g4eUpLR3B2QWZPT3BOS1drWkRTclhGd2ktYUdwSjZVZzhUaXFCWjVLc2x4SXZKbDVVaG9TQTlrSn

Dr Anne Simon (CHR Jolimont): «Les deux prochaines semaines seront déterminantes» - Sudinfo

📰 Sudinfo · 08/01/2022

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNa3ZnUlVRZjVFMEl1ZUUwOU1QUlBaMzJQSG1ZMC1PczVSczIwRTVNREQ0NGZTYVh0MXFqQ3o0ek9XX0g1UGxFdFpXMUJCekFpRk16WTdhWlJ4VkdOWjdzb19GN3hiREFRcFpFZVgzNG44a05aMURVbWp4amdreG1NSXZOSWlsb2ROWTlHRnd3UFhIZlF3Y1owel9kNDBwLTA1QWNhVWZpWDNLd0lhUERaRF8ybG5fWHZaVT

Coronavirus: vers un usage massif des masques FFP2? - Le Soir

📰 Le Soir · 06/01/2022

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOZjctRDEzamJnYUlqTTZiZ1NQX2dnR3lOUEJvLWhUd1ZkRW9LZFRMS2pJVk1iUVVfdzh3LV9iVUdHNGtlWHA0X3pBaWVOQ0lGdFJqc2Z4MnJ2S0w4N2pEQldYWXVlZHhFV1ZiUUhjeXcyLW9ybFRCYU85QlpCU2thaWt3UXg5cXJNUlRlNnZQQlMxS0M3OGV2dXc5czhqdw?oc=5" target="_blank">Coronavirus:

Nettoyeur vapeur: est-ce vraiment utile? - Femmes d'Aujourd'hui

📰 Femmes d'Aujourd'hui · 19/02/2021

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNTmNvYzJjWmFFLXFNWXdOdzVBUHRQOWlESGJtTGtfNk83Z1dXRWtZakhrMDZJQ181TEtjbTFwMGRsdjVoLUJseDgtNC1hZTFPMF9Rb2RTeDhKWmRkTkZyOXVwRGYwd0o5SGxRcEYtQ3VfYngyaE13Z0Q4OXZKT2t2LWlybkpaaG8?oc=5" target="_blank">Nettoyeur vapeur: est-ce vraiment utile?</a>

Ces nouveaux gestes de salut inspirés par le coronavirus - Le Soir

📰 Le Soir · 11/03/2020

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPM3gzV25UUjZCZTRnckJLdWM5WnA3aE5RT3VTektpeE1IeUxEam0tUEJReHdlUVkyOFhXX3BfY2J0MkFTNWFHUXlWX1o0OFBNUUV4ZHB2Y0YwUFlOcnJ5R0pNTlFFQXU2MlRzZ3lrSUVwZTVEVkNQRUN1SFF3WERqenNORmszSEVSRHdyUGhDMFBYM0tlX3M4TDNNWERhbXZrRG9fMHlkWQ?oc=5" target="_blank">C

Sprimont : avec des lampes UV anti-covid, l'atelier de mécanique PTS diversifie sa production - RTBF

📰 RTBF · 14/12/2020

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxObjZQN0ZpamdRdFc0MnZQV1ZUY21XZkZtX1VDSVlDYmhkcHB5dG5uV3JSSjhiUWZvWG1Rd0FiN094MlZhc05kX3czOUdoV2R1dkhPOUpCNEdXOHNKcUxuaVh2U0Q1Rjh5UnZWQnk3dEVuYncyZTc2c0p1Z2hKNjhySlNYdS1aNlNnRThYS2Z1N3B2N1d3eG94Wno3Nkk1M0xmUTBjemdzV2tJckhyaUxtMVE1Z0hYeC04eE

Top publications · les plus citées

The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist

Annals of the rheumatic diseases · 2022

📚 91 citations🎯 RCR 8.81Top 3% NIH🩺 Clinique🔓 Open Access📄 PDF gratuit ↗

Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts

Rheumatology (Oxford, England) · 2024

📚 27 citations🎯 RCR 7.00Top 5% NIH🔓 Open Access📄 PDF gratuit ↗

Lire l'abstract Crossref ↓

AbstractObjectivesAdult-onset Still’s disease (AOSD) is a rare condition characterized by fevers, rash, and arthralgia/arthritis; most doctors treating AOSD in the Netherlands treat &lt;5 patients per year. Currently, there is no internationally accepted treatment guideline for AOSD. The objectives of this study were to conduct a Delphi panel aimed at reaching consensus about diagnostic and treatment strategies for patients with AOSD and to use the outcomes as a basis for a treatment algorithm.MethodsThe Delphi panel brought together 18 AOSD experts: rheumatologists, internists and paediatricians. The Delphi process consisted of three rounds. In the first two rounds, online lists of questions and statements were completed. In the third round, final statements were discussed during a virtual meeting and a final vote took place. Consensus threshold was set at 80%. Two targeted literature searches were performed identifying the level of evidence of the consensus-based statements.ResultsConsensus was reached on 29 statements, including statements related to diagnosis and diagnostic tests, definition of response and remission, the therapy, the use of methotrexate and tapering of treatment. The panel consented on reduction of the use of glucocorticoids to avoid side effects, and preferred the use of biologics over conventional treatment. The role of IL-1 and IL-6 blocking agents was considered important in the treatment of AOSD.ConclusionIn this Delphi panel, a high level of consensus was achieved on recommendations for diagnosis and therapy of AOSD that can serve as a basis for a treatment guideline.

The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist

Arthritis & rheumatology (Hoboken, N.J.) · 2022

📚 26 citations🎯 RCR 2.73Top 18% NIH🔓 Open Access

Lire l'abstract Crossref ↓

BackgroundThe interleukin‐1 (IL‐1) mediated systemic autoinflammatory diseases, including the cryopyrin‐ associated periodic syndromes (CAPS), tumour necrosis factor receptor‐associated periodic syndrome (TRAPS), mevalonate kinase deficiency (MKD) and deficiency of the IL‐1 receptor antagonist (DIRA), belong to a group of rare immunodysregulatory diseases that primarily present in early childhood with variable multiorgan involvement. When untreated, patients with severe clinical phenotypes have a poor prognosis, and diagnosis and management of these patients can be challenging. However, approved treatments targeting the proinflammatory cytokine IL‐1 have been life changing and have significantly improved patient outcomes.ObjectiveTo establish evidence‐based recommendations for diagnosis, treatment and monitoring of patients with IL‐1 mediated autoinflammatory diseases to standardise their management.MethodsA multinational, multidisciplinary task force consisting of physician experts, including rheumatologists, patients or caregivers and allied healthcare professionals, was established. Evidence synthesis, including systematic literature review and expert consensus (Delphi) via surveys, was conducted. Consensus methodology was used to formulate and vote on statements to guide optimal patient care.ResultsThe task force devised five overarching principles, 14 statements related to diagnosis, 10 on therapy, and nine focused on long‐term monitoring that were evidence and/or consensus‐based for patients with IL‐1 mediated diseases. An outline was developed for disease‐specific monitoring of inflammation‐induced organ damage progression and reported treatments of CAPS, TRAPS, MKD and DIRA.ConclusionThe 2021 EULAR/American College of Rheumatology points to consider represent state‐of‐the‐art knowledge based on published data and expert opinion to guide diagnostic evaluation, treatment and monitoring of patients with CAPS, TRAPS, MKD and DIRA, and to standardise and improve care, quality of life and disease outcomes.

Cookies & analyse de trafic

MME Anne SIMON

Pourquoi vous devez consulter ce praticien

Activité de recherche & publications

Publications académiques en France

Lieu de consultation

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Articles de presse (10)

Top publications · les plus citées

Publications scientifiques (29) — classées par pathologie

Transversal13

Pédiatrie6

Génétique3

Fièvres auto-inflammatoires2

Goutte1

Lupus1

Ostéoporose1

Recommandations1

Vascularites des gros vaisseaux1

Datasets & protocoles partagés

Partager cette fiche